Blog

Photo taken from Zhen Su/LinkedIn

Apr 9, 2024, 15:02

Zhen Su: Really excited to see Pfizer leadership donated Bavencio US sales loyalty to American Association for Cancer Research

Zhen Su, CEO at Marengo Therapeutics, recently posted on LinkedIn:

“Really excited to see Pfizer leadership donated Bavencio US sales loyalty to American Association for Cancer Research to fund next-wave oncology innovation. A shoutout to Albert Bourla Chris Boshoff, and Mikael Dolsten for this transformative contribution to the cancer research community!
We are proud of the Merck Group and Pfizer Bavencio alliances and everyone who has contributed to this important partnership especially the early clinical trial investigators at the National Cancer Institute (NCI) led by Dr. James Gulley.”

Source: Zhen Su/LinkedIn

AACR Albert Bourla Chris Boshoff cancer Cancer research James Gulley Medical Partnership Merck Group Mikael Dolsten National Cancer Institute NCI OncoDaily Oncology Oncology Innovation pfizer Pfizer Bavencio

Overview of ASCO Breakthrough

Robert De Niro and Prostate Cancer: How He Went Against, How He Survived, and More

Isabel Mestres: In a world where the fight against cancer knows no borders, collaboration is not optional - it’s essential

Bernard Fox received SITC lifetime achievement award

Karen Knudsen: Better Together - Partnering to Accelerate Progress against Cancer

Special Coverage